We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+8.87%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$51.1B
AUM Growth
+$2.09B
(+4.3%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
22.51%
Holding
1,173
New
222
Increased
229
Reduced
441
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XEC
CIMAREX ENERGY CO
XEC
|
+$190M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$171M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$139M |
| 4 |
Textron
TXT
|
+$133M |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$325M |
| 2 |
EOG Resources
EOG
|
+$245M |
| 3 |
Honeywell
HON
|
+$186M |
| 4 |
Merck
MRK
|
+$149M |
| 5 |
Kohl's
KSS
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.75% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 14.77% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Communication Services | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
EPAM Systems
EPAM
$5.6B
| – | – |
-27,500
| Closed | -$10.9M |
|
1027
Element Solutions
ESI
$9.18B
| – | – |
-300,000
| Closed | -$5.49M |
|
1028
Edgewise Therapeutics
EWTX
$4.13B
| – | – |
-300,000
| Closed | -$9.75M |
|
|
FISV
1029
Fiserv Inc
FISV
$29B
| – | – |
-67,231
| Closed | -$8M |
|
1030
Golar LNG
GLNG
$5B
| – | – |
-1,625,000
| Closed | -$16.6M |
|
1031
Gentex
GNTX
$4.99B
| – | – |
-853,752
| Closed | -$30.5M |
|
1032
FerroAtlántica
GSM
$607M
| – | – |
-3,029,376
| Closed | -$11.5M |
|
1033
Hayward Holdings
HAYW
$3.28B
| – | – |
-1,600,000
| Closed | -$27M |
|
1034
HubSpot
HUBS
$12.3B
| – | – |
-15,000
| Closed | -$6.81M |
|
1035
Huntsman Corp
HUN
$1.76B
| – | – |
-200,000
| Closed | -$5.77M |
|
1036
ITT
ITT
$17.7B
| – | – |
-422,880
| Closed | -$38.4M |
|
1037
Karyopharm Therapeutics
KPTI
$44.6M
| – | – |
-89,987
| Closed | -$14.2M |
|
|
1038
Kohl's
KSS
$2.28B
| – | – |
-2,295,213
| Closed | -$137M |
|
1039
Legend Biotech
LEGN
$3.68B
| – | – |
-1,300,000
| Closed | -$37.7M |
|
1040
L3Harris
LHX
$51.7B
| – | – |
-49,504
| Closed | -$10M |
|
1041
Pulmonx
LUNG
$89.5M
| – | – |
-239,052
| Closed | -$10.9M |
|
1042
Masco
MAS
$14.7B
| – | – |
-281,700
| Closed | -$16.9M |
|
1043
MDU Resources
MDU
$4.2B
| – | – |
-1,577,931
| Closed | -$19M |
|
1044
MacroGenics
MGNX
$243M
| – | – |
-370,000
| Closed | -$11.8M |
|
1045
Myriad Genetics
MYGN
$285M
| – | – |
-150,000
| Closed | -$4.57M |
|
1046
Envista
NVST
$4.45B
| – | – |
-725,000
| Closed | -$29.6M |
|
1047
NextCure
NXTC
$17.9M
| – | – |
-12,500
| Closed | -$1.5M |
|
1048
Par Pacific Holdings
PARR
$4.16B
| – | – |
-1,000,000
| Closed | -$14.1M |
|
1049
Pfizer
PFE
$143B
| – | – |
-427,801
| Closed | -$15.5M |
|
1050
Insulet
PODD
$11.8B
| – | – |
-115,000
| Closed | -$30M |
|
Similar funds
Adage Capital Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Adage Capital Partners held 1,173 positions worth $51.1B, up 4.3% from $49B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Adage Capital Partners's Q2 2021 filing shows 222 new, 229 increased, 441 reduced and 163 closed positions. Its largest new stake was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M. The largest sale was GW Pharmaceuticals Plc American Depositary Shares, an estimated $325M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q2 2021 buy was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M.
- Adage Capital Partners added most to CIMAREX ENERGY CO in Q2 2021, an estimated $190M increase.
- Adage Capital Partners's biggest Q2 2021 reduction was EOG Resources, cutting an estimated $245M.
- Adage Capital Partners fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $325M.
- Adage Capital Partners's ten largest holdings make up 23% of its $51.1B portfolio in Q2 2021.
- Adage Capital Partners opened 222 new positions and closed 163 in Q2 2021.
- Adage Capital Partners's portfolio value rose 4.3% quarter-over-quarter to $51.1B.
Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.